AptaBio Therapeutics Inc. (293780.KQ)
KRW 6500.0
(-3.56%)
KRW 6500.0
(-3.56%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -14.09 Billion | -6.83 Billion | -8.89 Billion | -3.78 Billion | -6 Billion | -1.74 Billion |
| Net Income | -19.09 Billion | -10.56 Billion | -10.68 Billion | -3.91 Billion | -6.29 Billion | -4.06 Billion |
| Depreciation & Amortization | 500.1 Million | 460.39 Million | 320.07 Million | 250.01 Million | 95.5 Million | 9.75 Million |
| Deferred income taxes | -1.19 Billion | -1.11 Billion | -745.16 Million | -712 Million | -494.98 Million | - |
| Stock-based compensation | 186.65 Million | 123.59 Million | 137.5 Million | 180.57 Million | 488.5 Million | - |
| Change in working capital | -549.76 Million | -1.9 Million | -41.6 Million | 37.13 Million | -562.23 Million | 735.81 Million |
| Other non-cash items | 6.05 Billion | 4.26 Billion | 2.12 Billion | 377.75 Million | 893.07 Million | 736.76 Million |
| Investing Cash Flow | -12.73 Billion | 1.74 Billion | 1.13 Billion | 371.48 Million | -44.53 Billion | -7.68 Billion |
| Investments in PPE | -167.39 Million | -1.18 Billion | -169.17 Million | -2.07 Billion | -3.73 Billion | -27.67 Million |
| Acquisitions | -4.5 Billion | 1.00 | - | - | - | - |
| Investment purchases | -10.22 Billion | -2.87 Billion | -6 Billion | -3.19 Billion | -61.66 Billion | -17.64 Billion |
| Sales/Maturities of investments | - | 8.21 Billion | 7.33 Billion | 6.02 Billion | 20.88 Billion | 10.01 Billion |
| Other Investing Activities | -2.33 Billion | -2.4 Billion | -28.86 Million | -380.17 Million | -8.2 Million | -24.75 Million |
| Financing Cash Flow | 49.85 Billion | 496.01 Million | -375.68 Million | 1.5 Billion | 62.81 Billion | 10.92 Billion |
| Debt repayment | -38.89 Billion | -87.94 Million | -38.41 Million | -23.23 Million | -18.75 Million | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | -6.08 Million | 588.45 Million | -21.19 Million | 1.49 Billion | 62.74 Billion | 10.83 Billion |
| Other Financing Activities | 11.1 Billion | -749.08 Thousand | -314.24 Million | 41.65 Million | 91.7 Million | 83.3 Million |
| Accounts receivables | -5.51 Million | -69.36 Million | 32.48 Million | -31.4 Million | 60.57 Million | -36 Million |
| Accounts payables | - | - | - | - | - | 887.45 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | -544.25 Million | 67.45 Million | -74.08 Million | 68.53 Million | -622.8 Million | -115.63 Million |
| Cash at beginning of period | 2.98 Billion | 6.56 Billion | 14.68 Billion | 16.6 Billion | 4.31 Billion | 2.47 Billion |
| Cash at end of period | 26.01 Billion | 2.98 Billion | 6.56 Billion | 14.68 Billion | 16.6 Billion | 4.31 Billion |
| Capital Expenditure | -167.39 Million | -1.18 Billion | -169.17 Million | -2.07 Billion | -3.73 Billion | -27.67 Million |
| Effect of forex changes on cash | 5.07 Million | 16.75 Million | 20.09 Million | -9.75 Million | 11.91 Million | - |
| Net cash flow / Change in cash | 23.02 Billion | -3.57 Billion | -8.11 Billion | -1.91 Billion | 12.29 Billion | 1.83 Billion |
| Free Cash Flow | -14.26 Billion | -8.01 Billion | -9.06 Billion | -5.86 Billion | -9.74 Billion | -1.77 Billion |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -7.03 Billion | -3.96 Billion | -19.09 Billion | -8.3 Billion | -4.16 Billion | -2.15 Billion |
| Depreciation & Amortization | 132.49 Million | 120.11 Million | 500.1 Million | 123.56 Million | 122.91 Million | 124.48 Million |
| Deferred income taxes | - | - | -1.19 Billion | -317.99 Million | - | - |
| Stock-based compensation | - | 60.08 Million | 186.65 Million | 66.03 Million | - | 40.73 Million |
| Change in working capital | -1.96 Billion | -336.75 Million | -549.76 Million | -2.72 Billion | 1.88 Billion | 358.25 Million |
| Other non-cash items | 5.29 Billion | 2.38 Billion | 6.05 Billion | 3.2 Billion | 654.59 Million | 519.66 Million |
| Investing Cash Flow | 15.64 Billion | 3.54 Billion | -12.73 Billion | -599.79 Million | -20.64 Billion | 1.94 Billion |
| Investments in PPE | 3.56 Billion | - | -167.39 Million | 79.48 Million | -143.68 Million | -54.55 Million |
| Acquisitions | - | - | -4.5 Billion | - | - | - |
| Investment purchases | -2.3 Billion | -3 Million | -10.22 Billion | -727.14 Million | -9.49 Billion | 996.99 Million |
| Sales/Maturities of investments | 17.95 Billion | 3.91 Billion | - | - | -11 Billion | 1 Billion |
| Other Investing Activities | 15.64 Billion | -372.12 Million | -2.33 Billion | 47.86 Million | - | - |
| Financing Cash Flow | -36.62 Million | -35.01 Million | 49.85 Billion | -35.11 Million | 49.95 Billion | -34.74 Million |
| Debt repayment | -33.89 Million | -32.42 Million | -38.89 Billion | -1.63 Million | -38.9 Billion | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | -6.08 Million | - | -6.08 Million | - |
| Other Financing Activities | -2.72 Million | -2.59 Million | 11.1 Billion | 1.54 Million | 11.09 Billion | - |
| Accounts receivables | -724.99 Million | -401.45 Million | -5.51 Million | -4.84 Million | -26.31 Million | 122.06 Million |
| Accounts payables | 133.69 Million | 12.03 Million | - | - | - | - |
| Inventory | 32.87 Million | -32.87 Million | - | - | - | - |
| Other working capital | -1.27 Billion | 85.53 Million | -544.25 Million | -2.72 Billion | 1.91 Billion | 236.19 Million |
| Cash at beginning of period | 26.07 Billion | 26.01 Billion | 2.98 Billion | 33.62 Billion | 6.07 Billion | 6.43 Billion |
| Cash at end of period | 38.12 Billion | 26.07 Billion | 26.01 Billion | 26.01 Billion | 33.62 Billion | 6.07 Billion |
| Capital Expenditure | 3.56 Billion | - | -167.39 Million | 79.48 Million | -143.68 Million | -54.55 Million |
| Effect of forex changes on cash | 11.01 Million | 14.42 Million | 5.07 Million | -13.18 Million | 7.21 Million | 1.94 Million |
| Net cash flow / Change in cash | 12.04 Billion | 63.67 Million | 23.02 Billion | -7.6 Billion | 27.55 Billion | -366.93 Million |
| Free Cash Flow | -2.00 | -2.45 Billion | -14.26 Billion | -7.87 Billion | -1.91 Billion | -1.33 Billion |
950160
129260
JELLF
CPA
RSE
CANSF